Navigation Links
Columbia experts at American Assoc. for Cancer Research 2013 Annual Meeting
Date:4/3/2013

The following research from clinician-scientists at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center will be presented at the American Association for Cancer Research annual meeting, April 6, 2013, in Washington, DC.

EMBARGO NOTE: The embargo for all abstracts to be presented at the AACR Annual Meeting is in effect until the date and time of the presentation unless otherwise noted on the abstract and/or this summary. Please address any questions to the AACR media and public relations team.

Cancer Imaging in Mice and Men
Authors: Andrew Kung, MD, PhD, chief, Division of Pediatric Hematology/Oncology/Stem Cell Transplantation
Presentation Time: Sunday, April 7, 7:00 am:00 am

Major SymposiumThe Origins and Clinical Implications of Precancerous Lesions
Author: Cory Abate-Shen, PhD, professor of urology, director of research, Department of Urology
Presentation Time: Sunday, April 7, 1:00 pm:00 pm

The Interface Between Development and Cancer Using Model Organisms
Author: Michael Shen, PhD, professor of medicine and of genetics and development
Presentation Time: Sunday, April 7, 1:00 pm:00 pm

The Origins of Neoplastic Progression of Barrett's Esophagus
Author: Timothy C. Wang, MD, chief, Division of Digestive & Liver Diseases, Silberberg Professor of Medicine
Presentation Time: Sunday, April 7, 1:00 pm:00 pm

Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma (HCC) - Dysregulation of miR-483-5p and miR-150 as Diagnostic Marker
Author: Jing Shen, PhD, assistant professor of environmental health sciences
Presentation Time: Sunday, April 7, 1:00 pm:00 pm

Hiding from Chemo: Leukemia Cells Making Tumors to Survive [in Session: Role of Microenvironment in Tumor Dormancy and Resistance Niches]
Author: Isabel Cunningham, MD, adjunct associate research scientist, hematology oncology
Presentation Time: Sunday, April 7, 3:15 pm:15 pm

Loss of PTEN Expression Predicts Poor Prognosis in Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
Author: Dario Garcia-Carracedo, PhD, associate research scientist
Presentation Time: Monday, April 8, 1:00 pm:00 pm

Predictive Modeling of Cancer Treatment in Single Patients (N of 1)
Author: Andrea Califano, PhD, chief, Division of Biomedical Informatics, professor of systems biology (in biomedical informatics and the Institute for Cancer Genetics)
Presentation Time: Monday, April 8, 5:00 pm::30 pm

Inactivation of the Activin Signaling Pathway Accelerates the Development of Pancreatic Intraductal Papillary Mucinous Neoplasms in vivo
Author: Wanglong Qiu, MD, PhD, associate research scientist
Presentation Time: Tuesday April 9, 8:00 am:00 pm

Current Concepts in Diagnostics and Therapeutics Research - Next-Generation Therapeutic Modeling in Mice
Author: Cory Abate-Shen, PhD, professor of urology, director of research, Department of Urology
Presentation Time: Tuesday, April 9, 8:15 am:15 am

Cancer Targets and Discovery
Author: Andrea Califano, PhD, chief, Division of Biomedical Informatics, professor of systems biology (in biomedical informatics and the Institute for Cancer Genetics)
Presentation Time: Wednesday, April 10, 11:00 am:00 pm


'/>"/>

Contact: Elizabeth Streich
estreich@columbia.edu
212-305-3689
Columbia University Medical Center
Source:Eurekalert

Related medicine news :

1. Local Columbia Wellness Clinic, About Your Health, Announces GAPS Diet Practitioner
2. Snowstorms Blanketing the US Causing Major Outbreaks of Dry Skin, Columbia Healing Cream Reveals the Solution
3. Quality Associates to Digitize Confidential Case Files for the District of Columbia Courts
4. Pharmaceutical companies: An $84 million marketing effort in the District of Columbia
5. The Columbia Center for Theatrical Arts (CCTA) Announces Its Theater Program for Special Needs Youth
6. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
7. Factoring Receivables & Factoring Invoices Experts Universal Funding Announces Move
8. Springtime Allergies More Severe, Last Longer Now, Experts Say
9. Dr. Cindy Asbjornsen of the Vein Healthcare Center invited to participate in Sedona Days with other leading venous experts from around the world
10. Modest Cardiac Benefit From Chelation Therapy Not Enough to OK Use: Experts
11. Child Health Experts Come Out in Favor of Same-Sex Marriage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: